Greenland Mines Completes $12-Per-Share Equity Financing, Fully Funded Through 2027 Milestones with $42 Million, Terminates ATM, and Completes Sarfartoq Rare Earth Field Program

Financing and balance-sheet impact

Greenland Mines announced a registered direct offering and related warrant exercises that raised more than $42 million from existing investors. The company says this financing materially strengthens its balance sheet and provides capital it believes is required to execute planned exploration and development programs and achieve targeted 2027 milestones. The issuer framed the financing as sufficient for planned capital needs through those milestones.

Sources: S1

Termination of at-the-market facility

With planned capital needs described as substantially addressed by the financing, Greenland Mines terminated its at-the-market offering facility. The press release states the termination followed the completion and exercise of pre-funded warrants issued in the registered direct offering.

Sources: S1

Sarfartoq 2026 field program completed; assays pending

The company completed an approximately three-week geological and structural field program at the Sarfartoq NdPr Rare Earth Project, including detailed mapping, drone-supported outcrop surveying and systematic rock sampling across priority areas of the Sarfartoq Carbonatite Complex. Greenland Mines said samples will be submitted to a Canadian laboratory for rare earth element analysis, and the release notes that assay results have not yet been received.

Sources: S1

Existing ST1 mineral resource and technical context

Greenland Mines reported that Sarfartoq’s existing ST1 Mineral Resource comprises approximately 12.2 million tons grading 1.32% TREO and cited an independent Initial Assessment reporting a High-case pre-tax NPV8 of approximately $2.05 billion and a pre-tax IRR of 118.6%. The company described the field program as an early-stage geological mapping and sampling program and cautioned against interpreting the sampling as establishing grade, tonnage or economic viability.

Sources: S1

What remains uncertain

• All financing and milestone sufficiency claims are issuer statements and have not been independently verified in this release.
• Assay results from the Sarfartoq field program have not yet been received and the press release states that the field program was an early-stage geological mapping and sampling program.
• Forward-looking statements about achieving 2027 milestones, future programs, permits, financing, development decisions or production are subject to customary risks and uncertainties described by the company and in its SEC filings.